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Ureaplasma species are potentially pathogenic bacteria. Ureaplasma can cause inflammation
of the genitourinary system, obstetrical complications and can play a role in pathology of the
respiratory tract of premature newborns. The aim of this study was to evaluate the urease
activity of the human Ureaplasma species in vitro. Urease plays a key role in Ureaplasma
cells because its activity is the sole source of ATP production. It is considered that urease is
one of the virulence factors of these bacteria. We examined the ammonia product of urea
hydrolysis by U. parvum and U. urealyticum strains in two cell culture systems: A549- human
lung carcinoma cells and SiHa – human cervical carcinoma cells and in PPLO broth as a
control. Urease activity was assessed by measuring the concentration of ammonia, which was
based on the measurement of pH in cell culture medium and PPLO broth. Significantly higher
concentrations of ammonia were obtained for U. urealyticum as compared with U. parvum
only in A549 cells (Mann-Whitney U test P<0.0001). High ammonia levels observed after
inoculation of human cells with U. urealyticum suggest higher activity of the urease of this
species and may indicate a higher pathogenicity of this species particularly for the human
respiratory tract.
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Ureaplasmas are atypical bacteria, classified
within the Ureaplasma genus that belongs to the
Mycoplasmataceae family of the class Mollicutes.
These are the smallest and the simplest prokaryotic
organisms deprived of a bacterial cell wall. They
can cause infections of the human urogenital tract
and the respiratory system in preterm infants with
low birth weight (CASSELL et al. 1988a; CASSELL
et al. 1988b; CASSELL et al. 1993; ABELE-HORN
et al. 1997; HEGGIE et al. 2001; KATZ et al. 2005;
WAITES et al. 2005; VISCARDI & HASDAY 2009;
SALMERI et al. 2012).
Ureaplasmas differ from all other mycoplasmas
by possessing urease activity. Urease activity was
also demonstrated in a number of other bacteria
but ureaplasmas are the only representatives
whose growth is dependent on the presence of urea
(KENNY & CARTWRIGHT 1977). Urea hydrolysis
plays an important role in energy metabolism of
ureaplasmas and is their primary energy source.
Ureaplasmas produce as much as 95% of their
ATP in this reaction.
Ureaplasma urease activity is very high. This
enzyme is the major protein component of the cy-
toplasm (FORD & MACDONALD 1967; MASOVER
et al. 1977a; MASOVER et al. 1977b; ROMANO et al.
1980; ROMANO et al. 1986; SMITH et al. 1993).
Beside immunoglobulin A protease, phospholi-
pase A and C, multiple-banded antigen (MBA)
and an enzymatic system generating hydrogen
peroxide, urease of ureaplasmas is considered to
be a virulence factor that plays a role in the patho-
genesis of infections with these microbes (KILIAN
et al. 1984; LIGON & KENNY 1991; ZHENG et al.
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1995; KOKKAYIL & DHAWAN 2015). The differ-
ences in the activity of enzymes thought to be viru-
lence factors, including ureases, may be decisive
for the differences in the pathogenicity of the two
Ureaplasma species that infect humans. The
pathogenic effect of urease results from the gen-
eration of ammonia created as a product of hydro-
lytic decomposition of urea in the following
reaction: H2N-CO-NH2+H2O 2NH3+CO2
Ammonia released as a result of this reaction has
an irritating effect on the mucous membranes of
urogenital and respiratory systems which are the
targets for adherence and colonization of urea-
plasma strains (KONIECZNA et al. 2012; KOKKAYIL
& DHAWAN 2015; VISCARDI & SUHAS 2015).
The concentration of the produced ammonia indi-
rectly reflects the enzymatic activity of urease.
It is not definitively explained whether there are
differences in pathogenicity of either species of
Ureaplasma. Opinions on this subject are divided.
Our previous research shows that the less com-
monly isolated from newborns and adults U. urea-
lyticum exhibits higher pathogenicity. Newborns
infected with U. urealyticum were subject to more
frequent and longer therapeutic procedures sup-
porting respiration, needed more frequent surfactant
and antibiotic administration (BIERNAT-SUDOLSKA
et al. 2006b).
The aim of this study was to evaluate the urease
activity of the two human Ureaplasma species:
U. parvum and U. urealyticum since it is one of the
factors which may impact the pathogenicity of
these microorganisms.
Materials and Methods
Strains of ureaplasma
The study was conducted on 44 ureaplasma
strains, including 22 belonging to U. parvum and
22 from U. urealyticum. The strains were isolated
from tracheal aspirates of neonates hospitalized in
the Department of Neonatology, Jagiellonian Uni-
versity Medical College and from the urogenital
tract of women with inflammation of the urogeni-
tal system diagnosed at the Department of Micro-
biology, Jagiellonian University Medical College
in Cracow. All strains were previously identified
by PCR and stored at -70ºC until use in the present
experiment.
All ureaplasma strains were cultivated into liq-
uid and solid PPLO (pleuropneumonia like organ-
ism) media according to the procedure described
by Shepard (SHEPARD & LUNCEFORD 1976). The
liquid PPLO medium contained phenol red at a fi-
nal concentration of 0.002%, to detect an alkaline
shift in the medium. The addition of a colour indi-
cator to the liquid medium is necessary because the
growth of ureaplasmas does not cause turbidity of
the broth. The growth of ureaplasmas in liquid me-
dium was always confirmed by characteristic
ureaplasma colonies on PPLO agar. For identifica-
tion of species of ureaplasmas, species-specific
PCR was used according to a previous study
(BIERNAT-SUDOLSKA et al. 2006a).
Cell cultures and their inoculation with urea-
plasma strains
A culture of A549 cells (ATCC CCL-185) derived
from human lung was used as a model of respira-
tory infections which may develop in newborns af-
ter vertical transfer of these microorganisms from
the infected mother, and SiHa cell culture (ATCC
HTB-35) derived from the female genital tract was
used to approximate the conditions of genito-
urinary tract infection.
Cell cultures were maintained in flat tubes in Ea-
gle’s (Biovest-France) culture medium supple-
mented with 10% fetal calf serum and penicillin
(final concentration 100 U/ml), which does not af-
fect the proliferation of ureaplasmas, but limited
the growth of other bacteria. After inoculation of
cell cultures with ureaplasmas, Eagle’s medium
with 2% fetal calf serum was used. All cultures were
incubated at 37ºC in 5% CO2 in air for 18 hours.
For inoculation of cell cultures and PPLO broth as
a control of ureaplasmas growth, 0.2 ml of 18 hour
cultures of each strain was used. This volume rep-
resented 25% of the final volume of PPLO broth
and cell culture medium.
Examination of urease activity
The applied method is based on the assumption
that the concentration of ammonia formed in the
urea hydrolysis reaction can indirectly reflect the
urease activity (GLASS et al. 2000). The resulting
ammonia is clearly more basic (pKa value for am-
monia is 9.25) than carbon dioxide (pKa value for
H2CO3 is 6.35), meaning that the urease-catalyzed
reactions are accompanied by solution alkalization
and an increase in the pH value. The progress of
hydrolysis is monitored using the pH indicators:
bromothymol blue, phenolphthalein, phenol red
(routinely used in cell culture medium and in broth
for ureaplasmas), etc. (VANDEPITTE at al. 2003).
Thus, we suggested that the progress of the reac-
tion monitored by pH measurement, and the con-
centration of NH4OH, calculated on this basis,
equal to the concentration of NH3, can be an indi-
rect measure of the activity of the enzyme. This
method has proved useful for assessing the cata-
lytic activity of urease in ureaplasma cultures.
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Since the tested ureaplasma strains produced am-
monia at nanomolar concentrations (nM), it was
assumed, in accordance with the Ostwald’s dilu-
tion law describing the dependence of the degree
of dissociation of poor electrolyte on its concentra-
tions, that NH4OH, a poor electrolyte, in nanomo-
lar concentrations becomes a strong electrolyte
fully dissociated. Assuming the complete disso-
ciation of NH4OH, it was accepted at the same time
that the concentration of hydroxide ions (OH-) de-
rived from the base is equal to the concentration of
the base. Hydroxide ion concentration (OH-) de-
rived from ammonium base was calculated on the
basis of the measured pH, taking into account
(OH-) from the dissociation of water. The pH
value of the cell culture medium was measured us-
ing a pH-meter (Mettler Toledo). The NH4OH
concentration calculated from the pH measure-
ment was presented in nmol/liter, as the concentra-
tion of ammonia. The ureaplasma culture in PPLO
broth was used as a control system to provide opti-
mal growth conditions for these bacteria in vitro.
The pH was measured in PPLO broth and culture
medium from the cells 18 hours after inoculation.
The pH was also measured in PPLO broth and cul-
ture medium from cells uninfected by ureaplasmas
as a control. Concurrently with the inoculation, we
carried out a quantitative assessment of each test
strain by determining its titter, expressed as
CCU/ml (colour changing unit). The results for in-
dividual strains ranged from 101 to more than 109.
The number of CCU of the tested microorganisms
could, of course, affect the obtained ammonia con-
centration. To be able to compare the results for all
strains of ureaplasmas, the obtained value of am-
monia concentration was calculated per 100
CCU/ml for each strain. The values calculated per
100 CCU/ml were the basis for further calculations
of the average ammonia levels for both species of
ureaplasmas. Measurement of pH in the media of
uninfected ureaplasmas took into account in the
calculation of the ammonia concentration achieved
by each strain of ureaplasma. The results were ana-
lyzed statistically using the Mann-Whitney U test
and Kruskal-Wallis test. Statistica version 10 was
used for the calculations.
Results and Discussion
The mean of concentrations of ammonia calcu-
lated per 100 CCU/ml bacteria used for inocula-
tion of A549 and SiHa cell cultures and PPLO
broth as a control for both Ureaplasma species are
presented in Fig. 1 and Fig. 2.
A significantly higher concentration of ammo-
nia was obtained in A549 cells infected with
U. urealyticum compared with cells infected with
U. parvum (Mann-Whitney U test P<0.0001) (Fig. 3).
Differences in ammonia concentration achieved in
SiHa cells infected with U. parvum and U. urea-
lyticum were not statistically significant.
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Fig. 1. Ammonia concentrations achieved in the human lung
cells (A549), cervical cancer cells (SiHa) and PPLO broth
inoculated with the 22 clinical strains of U. parvum.
Fig. 2. Ammonia concentrations achieved in the human lung
cells (A549), cervical cancer cells (SiHa) and PPLO broth
inoculated with the 22 clinical strains of U. urealyticum.
Fig. 3. Comparison of urease activity in the human lung cells
(A549) inoculated with the 22 clinical strains of U. parvum
and U. urealyticum.
Urease is produced by many bacteria which are
pathogenic to humans. Numerous reports on its
role in the pathogenesis of infections with these
microbes have been published (SENIOR et al.
1980; MOBLEY et al. 1991; MOBLEY et al. 1995;
SANGARI et al. 2007; ZHANG et al. 2013). It is
known that urease is a virulence factor in infec-
tions of the urinary tract, including e.g. Proteus,
Klebsiella, gastrointestinal system, e.g. H. pylori,
Shigella, Yersinia, Brucella and respiratory tract
e.g. H. influenzae, M. tuberculosis (MOBLEY et al.
1991; COLLINS & ORAZIO 1993; GORDEN &
SMALL 1993; JOHNSON et al. 1993).
Urease activity can be tested in two ways: by
showing the loss of the substrate or the pres-
ence/growth of the product formed by the
enzyme-catalyzed reaction. There are many meth-
ods for the detection of ammonia released by the
action of urease, which may be based on vacuum
distillation, microdiffusion, steam distillation or
electrical conductivity measurement (VAN SLYKE
1927; KATZ 1964; KALTWASSER & SCHLEGEL
1966; RUIZ-HERRERA & GONZALEZ 1969;
MCDONALD et al. 1972; SHAIK et al. 1980).
Various techniques have been applied for the
measurement of ammonia concentration, most
commonly using the modified method of Bertholet
(SMITH et al. 1993; SANGARI et al. 2007) or the
method of Weatherburn (WEATHERBURN 1967).
In contrast to the classical method of Bertholet, we
used the method based on pH measurement which
allows for an estimation of the urease activity, to
assess the concentration of ammonia in the color
solution in culture media of A549 and SiHa cells
and PPLO broth.
Currently 14 serotypes of ureaplasmas were
classified into 2 species U. parvum and U. urea-
lyticum. The species of U. parvum is more com-
mon in human infection. It is an open question
whether and how much the ureaplasma serotypes
or species differ in pathogenicity.
Conflicting reports on this subject appear in the
literature (WAITES et al. 2005; CULTRERA et al. 2006;
BIERNAT-SUDOLSKA et al. 2006b; ONDONDO et al.
2010). Our earlier observations suggested a higher
pathogenicity of the U. urealyticum species
(BIERNAT-SUDOLSKA et al. 2006a). It is not
known what underlies the differences in pathogen-
icity. Possibly, they originate from differences at
the molecular level. Hence, to address this prob-
lem, a variety of aspects should be considered,
such as easier horizontal gene transfer, greater
variability of surface proteins facilitating escape
from the host defence system, higher resistance to
drugs or higher activity of enzymes believed to be
important virulence factors, like urease, protease
and lipase.
We attempted to assess the activity of urease,
a key enzyme for ureaplasmas. This enzyme is im-
portant for the energy metabolism of ureaplasma
cells, but also, by generating ammonia, it produces
local cytotoxic effects on the mucous membranes
colonized by ureaplasmas. Urease can be lethal to
animals after intravenous administration (LIGON
& KENNY 1991).
Previous research has shown that this enzyme
also allows the survival of bacteria in host tissues
(MOBLEY et al. 1991; COLLINS & ORAZIO 1993;
GORDEN & SMALL 1993; JOHNSON et al. 1993;
SANGARI et al. 2007). Recently, it has been shown
that urease also plays a role in respiratory infec-
tions. Since urea is translocated to the surface of
the airway epithelium and is present in concentra-
tions comparable to the concentrations in the
plasma, the presence of urease is also essential for
the survival and replication of bacteria causing in-
fections of the respiratory system for example, in
infections with M. tuberculosis (for survival within
macrophages and as the sole nitrogen source in the
environment in which they multiply) or H. influenza
for facilitating the assimilation of nitrogen in the
environment of the human respiratory tract
(OLIVERA-SEVERO et al. 2006; MURPHY & BRAUER
2011; LIN et al. 2012).
Urease is targeted by human antibodies in the
humoral response, and the presence of anti-urease
antibodies correlated with the severity of the dis-
ease (FUTAGAMI et al.1998). In addition, urease
was identified as an immunomodulator of devel-
oping inflammatory response (WILSON et al. 2000;
KONIECZNA et al. 2012), thus, it can play a role in
pathogenesis, irrespective of the enzymatic activ-
ity. This protein acts by several other mechanisms,
including the ability to activate macrophages
(HARRIS et al. 1998), to induce inflammatory me-
diators (HARRIS et al. 1996; TANAHASHI et al.
2000; ZHANG et al. 2011), apoptosis (FAN et al.
2000) and to facilitate survival of bacteria in
macrophages (SCHWARTZ & ALLEN 2006; MAKRI-
STATHIS et al. 1998).
In our study, a high concentration of ammonia
was demonstrated for U. urealyticum in the culture
of A549 cells derived from human lung. Our re-
sults can suggest a higher urease activity of
U. urealyticum in the lung tissue and can explain
the more severe pneumonia in newborns infected
by U. urealyticum compared to babies infected by
U. parvum. ABELE-HORN et al. (1997) suggested
that U. urealyticum was the dominant species,
compared to U. parvum in patients with pelvic in-
flammatory disease and might have a greater nega-
tive impact on pregnancy, neonatal birth weight,
gestational age, and the possibility of preterm de-
livery. Our results have indicated that urease activ-
ity of U. urealyticum is higher in cervix cells,
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which, by analogy to other microorganisms, can
promote the survival of these bacteria in the uro-
genital system and facilitate the ascending infec-
tion of particular importance in pregnant women.
We showed a wide disparity between the con-
centrations of ammonia (Fig. 1 and Fig. 2) ob-
served in strains belonging to both ureaplasma
species. These differences most likely result from
genetic differences not only between species but
also between ureaplasma serotypes. The most re-
cent studies indicate the existence of such differ-
ences at the molecular level (PARALANOV et al.
2012; ZHANG et al. 2013). The various serotypes
classified as one species differ from one another to
a varying extent. The average level of percent dif-
ference in U. urealyticum species was 0.62% and
9.5% in U. parvum species (PARALANOV et al.
2012). In clinical practice, also chimeric urea-
plasma strains were isolated, suggesting the exis-
tence of recombinant mechanisms also in this
group of microorganisms. Perhaps ureaplasmas
are a dynamic population, and not a population
with stable genotypes, as suggested by the authors
of the above paper. At present, clear identification
of a gene/group of genes critical for ureaplasma
virulence is impossible. It should be remembered
that on the one hand, patient’s clinical condition
depends on the pathogen-related factors, e.g. the
presence or lack of the genes responsible for viru-
lence, and on the other, on the defence mecha-
nisms of the host. Future research of Ureaplasma
biology should focus on the molecular aspects of
their diversity, which was postulated, among oth-
ers by Paralanov (PARALANOV et al. 2012).
Conclusions
1. High ammonia levels observed after infection
of human culture cells with U. urealyticum suggest
a higher enzymatic activity of urease of this spe-
cies.
2. Higher urease activity of U. urealyticum in
A549 cell culture may indicate a higher pathogen-
icity of this species particularly for respiratory
tract cells and may explain the damage observed in
preterm infants vertically infected with U. urea-
lyticum.
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